Ignite Creation Date:
2024-05-06 @ 12:46 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03841591
Status:
COMPLETED
Last Update Posted:
2019-02-15
First Post:
2019-02-13
Brief Title:
Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Insulin has many disadvantages for mothers with GDM including the need to give injections frequent daily testing for monitoring and risks of hypoglycemia increase in appetite weight gain and high cost Metformin an oral biguanide may be a more logical alternative to insulin for women with GDM who are unable to cope with the increasing insulin resistance of pregnancy
This study aim to compare maternal weight gain during pregnancy in women with gestational diabetes treated by insulin versus metformin
This study aim to compare maternal weight gain during pregnancy in women with gestational diabetes treated by insulin versus metformin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None